Hyaluronic acid: A key ingredient in the therapy of inflammation

A Marinho, C Nunes, S Reis - Biomolecules, 2021 - mdpi.com
Hyaluronic acid (HA) is a natural polymer, produced endogenously by the human body,
which has unique physicochemical and biological properties, exhibiting desirable …

Injectable drug delivery systems for osteoarthritis and rheumatoid arthritis

MC Bruno, MC Cristiano, C Celia, N d'Avanzo… - ACS …, 2022 - ACS Publications
Joint diseases are one of the most common causes of morbidity and disability worldwide.
The main diseases that affect joint cartilage are osteoarthritis and rheumatoid arthritis, which …

Rheumatoid arthritis microenvironment insights into treatment effect of nanomaterials

Y Zhu, T Zhao, M Liu, S Wang, S Liu, Y Yang, Y Yang… - Nano Today, 2022 - Elsevier
Rheumatoid arthritis (RA) causes a huge medical burden due to its high morbidity and
disability rate. Emerging evidences demonstrate that RA has a tumor-like microenvironment …

Oral administration of multistage albumin nanomedicine depots (MANDs) for targeted efficient alleviation of chronic inflammatory diseases

F Zhang, Y Du, J Zheng, Z Cai, T Ding… - Advanced Functional …, 2023 - Wiley Online Library
Methotrexate (MTX) by oral taking has been employed as the first‐line medication for
various chronic inflammatory diseases treatment, such as Crohn's disease and rheumatoid …

Exploring the potential of hydroxyapatite-based materials in biomedicine: A comprehensive review

C Liu, M Xu, Y Wang, Q Yin, J Hu, H Chen… - Materials Science and …, 2024 - Elsevier
Hydroxyapatite (HA), which shares similarities in both chemical composition and structure
with bone phosphate systems, and has garnered significant attention in biomedicine due to …

[HTML][HTML] Nanomaterial-assisted theranosis of bone diseases

K Zheng, J Bai, H Yang, Y Xu, G Pan, H Wang… - Bioactive Materials, 2023 - Elsevier
Bone-related diseases refer to a group of skeletal disorders that are characterized by bone
and cartilage destruction. Conventional approaches can regulate bone homeostasis to a …

Recent advances in nano-targeting drug delivery systems for rheumatoid arthritis treatment

H Li, R Gou, J Liao, Y Wang, R Qu, Q Tang… - Acta Materia …, 2023 - scienceopen.com
Rheumatoid arthritis is a systemic inflammatory disease that can lead to articular cartilage
destruction and periarticular bone erosion, thus ultimately compromising joint integrity and …

A comprehensive review of advanced drug delivery systems for the treatment of rheumatoid arthritis

Q Shen, Y Du - International Journal of Pharmaceutics, 2023 - Elsevier
Rheumatoid arthritis (RA), a chronic autoimmune disease, is characterized by articular pain
and swelling, synovial hyperplasia, and cartilage and bone destruction. Conventional …

Recent innovations in topical delivery for management of rheumatoid arthritis: a focus on combination drug delivery

S Karnam, MR Donthi, AB Jindal, AT Paul - Drug Discovery Today, 2024 - Elsevier
Highlights•Elucidation of the intricate mechanism involved in the pathogenesis of
rheumatoid arthritis.•Combination delivery in clinical trials and preclinical models.•Topical …

Nanotechnology-empowered combination therapy for rheumatoid arthritis: Principles, strategies, and challenges

S Ren, Y Xu, X Dong, Q Mu, X Chen, Y Yu… - Journal of …, 2024 - Springer
Rheumatoid arthritis (RA) is an autoimmune disease with multifactorial etiology and intricate
pathogenesis. In RA, repeated monotherapy is frequently associated with inadequate …